ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

4.60
Delayed Data
As of 2:14pm ET
 -0.20 / -4.17%
Today’s Change
0.65
Today|||52-Week Range
5.15
+107.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$106.9M

Company Description

ContraVir Pharmaceuticals, Inc. is a development stage biopharmaceutical company which is focused primarily on the development of drugs to treat herpes zoster, or shingles. The company currently developing a compound called FV-100 for the treatment of shingles. ContraVir Pharmaceuticals was founded on May 15, 2013 and is Headquartered in New York, NY.

Contact Information

ContraVir Pharmaceuticals, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 297-0020
Investor Relations:
(212) 584-7610

Employees

Shareholders

Individual stakeholders0.16%
Mutual fund holders0.04%
Other institutional0.00%

Top Executives

James E. SapirsteinChief Executive Officer & Director
William HornungChief Financial Officer
John Z. Sullivan-BólyaiChief Medical Officer
Gem GokmenHead-Media Relations

To view my watchlist

Not a member yet?

Sign up now for a free account